Prioritising Lung Health: How FeNO can help to tackle Lung Conditions, the UK’s 3rd Largest Threat

Sign up for free to read a limited number of articles each month. Pick what newsletters get delivered to your inbox each week. Biopharma ENDPOINTS

Blood biomarkers at disease onset may help predict relapse-associated worsening and progression independent of relapse activity (PIRA) in multiple sclerosis (MS), an observational study suggested.